InspireMD
Miami, Florida, United States · Biotechnology, Healthcare, Health Care
InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise—delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prol
Key facts
- Headquarters
- Miami, Florida, United States
- Employees
- 85
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (NSPR)
- Website
- inspiremd.com
- Company page
Recent activity at InspireMD
- : InspireMD Appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
- : InspireMD Appoints Peter A. Soukas, M.D. as Chief Medical Officer
- : InspireMD
- : InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
- : InspireMD
- : InspireMD, Inc.
- : InspireMD, Inc.
- : InspireMD, Inc.
InspireMD funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Venture | $40.1M |
| May 2023 | Venture | $42.2M |
| Dec 2017 | Venture | $750K |
| Jun 2016 | Pre-Seed | $182K |
| Mar 2016 | Venture | $610K |
Leadership
- Thomas Kester, Director
- Campbell Rogers, Director
- Michael Berman, Director
- Paul Stuka, Director
- James Barry, Executive Officer, Director
- Paul Stuke, Director
- Campbell Rogers, Director
- James Loughlin, Director
- Michael Berman, Director
- Isaac Blech, Director
- Sol Barer, Director
- James Barry, Executive Officer, Director
Verified email and direct lines for InspireMD’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
InspireMD in the news
- InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times (Sep 03, 2026)
- InspireMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance (Aug 17, 2026)
- InspireMD adds former Axonics co-founder, CFO to board - MassDevice (Sep 17, 2025)
- Medical device company to part ways with COO - The Business Journals (Mar 05, 2026)
- InspireMD Inc (NSPR) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges While ... - Yahoo Finance (Aug 17, 2026)
- InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire (Nov 08, 2024)
- InspireMD (Nasdaq:NSPR) - Stock Analysis - Simply Wall Street (May 22, 2021)
- InspireMD (NSPR) Stock Price, News & Analysis - MarketBeat (Sep 21, 2020)
Companies similar to InspireMD
- PROTEOR · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
- IceCure Medical · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
- Cornerstone Robotics · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
- Shape Memory Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- Andersen Sterilizers · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
About InspireMD: questions and answers
What does InspireMD do?
InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company dedicated to helping prevent stroke and save lives. We empower physicians and patients to choose carotid stenting without compromise—delivering smart design for stroke prevention through our proprietary MicroNet™ mesh technology. Uniquely engineered on the outside of the stent scaffold, our mesh is designed to reduce plaque prol
Where is InspireMD headquartered?
InspireMD is headquartered in Miami, Florida, United States.
How many employees does InspireMD have?
InspireMD has about 85 employees.
Has InspireMD raised funding?
Yes. Fundz has recorded 5 funding events for InspireMD. The most recent, $40.1M, was in Aug 2025.
What is the latest news on InspireMD?
On Jul 30, 2026, InspireMD Appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
Is InspireMD a public company?
Yes. InspireMD is publicly traded under the ticker NSPR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy